Morphine (Chlorhydrate) Lavoisier (Morphine Hydrochloride)

Morphine is an opioid analgesic that acts on the central nervous system to relieve intense pain. It is indicated for:

• Severe acute pain: provides rapid relief after trauma or surgery.
• Post‑operative pain: controls pain following major operative procedures.
• Cancer‑related pain: manages moderate to severe pain associated with malignant disease.
• Chronic severe pain: used when other analgesics are insufficient, under strict medical supervision.

• Morphine hydrochloride binds as an agonist to mu‑opioid receptors in the brain, spinal cord and peripheral nervous system. Activation of these G‑protein‑coupled receptors inhibits adenylate cyclase, reduces calcium influx, and increases potassium efflux, leading to decreased neuronal excitability and diminished transmission of nociceptive signals, thereby producing analgesia.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea: feeling of sickness often accompanied by vomiting.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sedation and reduced alertness.
• Itching: pruritus, especially around the face and neck.
• Sweating: excessive perspiration unrelated to temperature.
• Dry mouth: reduced salivation causing discomfort.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be fatal.
• Severe hypotension: marked drop in blood pressure causing dizziness.
• Adrenal insufficiency: impaired cortisol production.
• Dependence and withdrawal: physical reliance with withdrawal symptoms on abrupt cessation.
• Anaphylaxis: rare severe allergic reaction with rash, swelling, and airway compromise.
• Cardiac arrhythmias: irregular heart rhythms in susceptible individuals.

Morphine requires careful monitoring due to its potency and risk profile.

• Respiratory monitoring: assess breathing rate and depth regularly, especially after dose changes.
• Cardiovascular assessment: watch for hypotension and treat promptly if symptomatic.
• Renal/hepatic impairment: adjust dosing in patients with reduced organ function.
• Allergy screening: avoid use in individuals with known hypersensitivity to morphine or other opioids.
• Pregnancy and lactation: risk unknown; reserve for situations where benefit outweighs potential harm.
• Store below 25°C: keep in original container, protect from light and moisture.

Morphine can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound sedation or respiratory depression.
• MAO inhibitors: can precipitate severe hypertension or serotonin syndrome.
• Respiratory depressants (e.g., anesthetic gases): increase risk of fatal respiratory failure.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may raise morphine plasma levels.
• CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect.
• Diuretics: can enhance hypotensive effects.
• Antihistamines: may increase sedation and dizziness.